Clinician-scientists at Stanford have proposed a WNT formulation that, when used in combination with a first-of-its-kind normothermic perfusion device, reconditions marginal organs and enables their safe transplantation.
Stanford inventors have developed a mobile thermoelectric device designed to preserve organs during transit by maintaining 10°C (+/-1°C) for over 6 hours.
Researchers in the Nakauchi lab at Stanford University have shown that the contribution of human donor cells to tissues and organs can be increased in an interspecies host embryo by knocking out insulin growth factor 1 receptor (Igf1r).
Researchers at Stanford have developed a method of preventing Graft versus Host Disease (GVHD) by inhibiting a specific immune receptor. GVHD is a major debilitating complication of transplantation.